INS and obesity disorder: It is important to consider that a detrimental role of IL-6 exists [37,42] and that obesity particularly increases IL-6 levels both in humans and mice due to macrophage secretion in the adipose tissue [50], promoting a low-grade systemic inflammation that can impair insulin signaling and glucose metabolism [45].